Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

AGM 2020 Presentation

November 18, 2020November 18, 2020 Alterity Therapeutics

AGM 2020 Presentation

Post navigation

Chairman’s Address to Shareholders 2020 Annual General Meeting

Alterity presents at Finance News Network investor event

Related Posts

Prana to commence Phase 1 clinical trial of PBT434 for treatment of parkinsonian diseases

June 13, 2018

Alterity’s lead drug candidate receives positive opinion from European medical agency

November 18, 2019January 7, 2021

Prana receives A$3.3 million R&D Tax Incentive

March 18, 2019

Leave a Reply Cancel reply

Your email address will not be published.Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Recent Posts

Alterity CEO David Stamler presents to US investors at the HC Wainwright Global Life Science Conference
Alterity to present at the 7th International Congress of Multiple System Atrophy
Alterity Half Year Results and Investor Webcast Notification
Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials
Quarterly Cash Flow Report

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065